Continued presence of intrastriatal but not intraventricular polymer- encapsulated PC12 cells is required for alleviation of behavioral deficits in Parkinsonian rodents

Cell Transplantation

Volumn 5, Issue 5, 1996, Pages 589-596

  Emerich, Dwaine F ^a   Winn, Shelley R ^a   Lindner, Mark D ^a  

^a CytoTherapeutics Inc   (United States)

Author keywords

Dopamine; Encapsulation; Parkinson's disease; PC12 cells; Striatum; Transplantation

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; OXIDOPAMINE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DOPAMINE RELEASE; ENCAPSULATION; MALE; NONHUMAN; PARKINSON DISEASE; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

ANIMALIA; PARKINSONIA; RODENTIA;

EID: 0029762886     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/0963-6897(96)00086-3     Document Type: Article

References (35)

1. Aebischer, P.; Tresco, P.A.; Winn, S.R.; Greene, L.A.; Jaeger, C.B. Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp. Neurol. 111:269-275; 1991.
2. Aebischer, P.; Wahlberg, L.; Tresco, P.A.; Winn, S.R. Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution. Biomaterials 12: 50-56; 1991.
3. Aebischer, P.; Goddard, M.; Signore, A.P.; Timpson, R.L. Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Exp. Neurol. 126:151-158; 1994.
4. Ahlskog, J.E.; Kelly, P.J.; Van Heerden, J.A.; Stoddard, S.L.; Tyce, G.M. Windebank, A.J.; Bailey, P.A.; Bell, G.N.; Blexrud, M.D.; Carmichael, S.W. Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies. Mayo Clin. Proc. 65:305-328; 1990.
5. Bjorklund, A.; Dunnett, S.B.; Stenevi, U.; Lewis, M.E.; Iversen, S.D. Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199:307-333; 1980.
6. 3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy. Eur. J. Pharmacol. 99:167-175; 1984.
7. Cabasso, I. Hollow fiber membranes. In: Othmer, K., ed. Encyclopedia of chemical technology. New York: Wiley; 1980:492-517.
8. Dunnett, S.B.; Bjorklund, A.; Stenevi, U.; Iversen, S.D. Grafts of embryonic nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res. 229:209-217; 1981.
9. Dunnett, S.B.; Bjorklund, A.; Stenevi, U.; Iversen, S.D. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions. Brain Res. 215:147-161; 1981.
10. Dunnett, S.B.; Bjorklund, A.; Schmidt, R.H.; Stenevi, U.; Iversen, S.D. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol. Scand. Suppl. 522:29-37; 1983.
11. Emerich, D.F.; Winn, S.R.; Christenson, L.; Palmatier, M.; Gentile, F.T.; Sanberg, P.R. A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy. Neurosci. Biobehav. Rev. 16: 437-447; 1992.
12. Emerich, D.F.; Frydel, B.R.; Flanagan, T.R.; Palmatier, M.; Winn, S.R.; Christensen, L. Transplantation of polymer encapsulated PC12 cells: Use of chitosan as an immobilization matrix. Cell Transplant. 2:241-249; 1993.
13. Emerich, D.F.; McDermott, P.E.; Krueger, P.M.; Frydel, B.R.; Sanberg, P.R.; Winn, S.R. Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats. Exp. Neurol. 122:37-47; 1993.
14. Emerich, D.F.; McDermott, P.E.; Krueger, P.M.; Winn S.R.. Intrastriatal implants of polymer-encapsulated PC12 cells effects on motor function in aged rats. Prog. Neuropsychol. Biol. Psychol. 18(5):935-946; 1994.
15. 3H] spiroperidol autoradiography. In: Bjorklund, A.; Stenevi, U., eds. Neural grafting in the mammalian CNS. New York: Elsevier Science Publishers; 1985:471-489.
16. Freed, W.J.; Poltorak, M.; Becker, J.B. Intracerebral adrenal medulla grafts: A review. Exp. Neurol. 110:139-166; 1990.
17. Freed, W.J. Substantia nigra grafts and Parkinson's disease: From animal experiments to human therapeutic trials. Restor. Neurol. Neurosci. 3:109-134; 1991.
18. Freeman, T.B.; Olanow, C.W.; Hauser, R.A.; Nauert, G.M.; Smith, D.A.; Borlongan, C.V.; Sanberg, P.R.; Holt, D.A.; Kordower, J.H.; Vingerhoets, J.G.; Snow, B.J.; Clane, D.; Gauger, L.L. Bilateral fetal nigral transplantation into the postcommisural putamen in Parkinson's disease. Ann. Neurol. 38:379-388; 1995.
19. Goetz, C.G.; Tanner, C.M.; Penn, R.D.; Stebbins, G.T.; Gilley, D.W.; Shannon, K.M.; Klawans, H.L.; Comelia, C.L.; Wilson, R.S.; Witt, T. Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data. Neurology 40: 273-276; 1990.
20. Hornykiewicz, O. Parkinson's disease and its chemotherapy. Biochem. Pharmacol. 24:1061-1065; 1975.
21. Hughes, A.J.; Daniel, S.E.; Blankson, S.; Lees, A.J. A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neurol. 50:140-148; 1993.
22. Kordower, J.H.; Fiandaca, M.S.; Notter, M.F.D.; Hansen, J.T.; Gash, D.M. Scientific basis for dopaminergic brain grafting. In: Koller, W.C.; Paulson, G., eds. Therapy of Parkinson's disease. New York: Marcel Dekker, Inc.; 1990:443-472.
23. Kordower, J.H.; Liu, Y-T.; Winn, S.R.; Emerich, D.F. Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: A behavioral, neuroanatomical and neurochemical analysis. Cell Transplant. 4:155-171; 1995.
24. Leenders, K.L.; Salmon, E.P.; Tyrell, P.; Perani, D.; Brooks, D.J.; Sager, H.; Jones, T.; Marsden, C.D.; Frackowiak, R.S. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch. Neurol. 47:1290-1298; 1990.
25. Lindner, M.D.; Winn, S.R.; Baetge, E.E.; Hammang, J.P.; Gentile, F.T.; Doherty, E.; McDermott, P.E.; Frydel, B.R.; Ullman, D.; Schallert, T.; Emerich, D.F. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp. Neurol. 132:62-76; 1995.
26. Lindvall, O.; Rehncrona, S.; Brundin, P.; Gustavii, B.; Astedt, B.; Widner, H.; Lindholm, T.; Bjorklund, A.; Leenders, K.L.; Rothwell, J.C. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46:615-631; 1989.
27. Lindvall, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustavii, B.; Frackowiak, R.; Leenders, K.L.; Sawle, G.; Rothwell, J.C.; Marsden, C.D. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577; 1990.
28. Lindvall, O.; Widner, H.; Rehncrona, S.; Brundin, P.; Odin, P.; Gustavii, B.; Frackowiak, R.; Leenders, K.L.; Sawle, G.; Rothwell, J.C. Transplantation of fetal dopamine neurons in Parkinson's disease: One-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:155-165; 1992.
29. Lindvall, O.; Sawle, G.; Widner, H.; Rothwell, J.C.; Bjorklund, A.; Brooks, D.; Brundin, P.; Frackowiak, R.; Marsden, C.D.; Odin, P. Rehncrona, S. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinsons Disease. Ann. Neurol. 35(2):172-180; 1994.
30. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press; 1986.
31. SAS Institute Inc. SAS/STAT User's Guide, Version 6, 4th ed. Vol. 1. Cary, NC: SAS Institute Inc.; 1989.
32. Tresco, P.A.; Winn, S.R.; Aebischer, P. Polymer encapsulated neurotransmitter secreting cells: Potential treatment for Parkinson's disease. ASAIO J. 38:17-23; 1992.
33. Tresco, P.A.; Winn, S.R.; Tan, S.; Jaeger, C.B.; Greene, L.A.; Aebischer, P. Polymer-encapsulated PC12 cells: Long-term survival and associated reduction in lesion-induced rotational behavior. Cell Transplant. 1:255-264; 1992.
34. Winn, S.R.; Wahlberg, L.; Tresco, P.A.; Aebischer, P. An encapsulated dopamine-releasing polymer alleviates experimental Parkinsonism in rats. Exp. Neurol. 105:244-250; 1989.
35. Winn, S.R.; Tresco, P.A.; Zielinski, B; Greene, L.A.; Jaeger, C.B.; Aebischer, P. Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp. Neurol. 113:322-329; 1991.